DOI: https://doi.org/10.14710/jbtr.v7i3.12257

Melatonin, A Promising Therapeutic for Diabetes Mellitus and Its Complications: A Narrative Review

1Faculty of Medicine, University of Muhammadiyah, Indonesia

2Faculty of Mathematics and Natural Sciences, State University of Semarang, Indonesia

Received: 28 Oct 2021; Revised: 10 Nov 2021; Accepted: 29 Dec 2021; Available online: 31 Dec 2021; Published: 31 Dec 2021.
Open Access Copyright (c) 2021 Journal of Biomedicine and Translational Research
Creative Commons License This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Citation Format:
Abstract
Diabetes mellitus (DM) is a non-communicable disease and still a health problem in the world. Melatonin is responsible to metabolize carbohydrate and regulate blood sugar levels. Several studies proved Melatonin is useful in the diabetes therapy and its complication by performing antioxidant activity through various signaling pathways. The role of the melatonin hormone in the pathogenesis of complications of diabetes mellitus is still a lot of controversy. Animal studies are still incomplete to explain the mechanism of action of melatonin. Therefore, this review aims to discuss Melatonin role administration in DM and its complications. This review was started by searching articles using electronic databases such as Google Scholar, Science Direct, SpringerLink and Pubmed between 2009-2019. Melatonin increased respiration within mitochondria; acted as antioxidant that fight free radical production; and reduced oxidative stress. It diminished proinflammatory cytokines in diabetes and prevents various DM complications on eyes, cardiac and male reproductive organs through antioxidant effects. It inhibited proinflammatory within several signaling Pathways, included PI3K/Akt-Nrf2,cGMP-PKG, Nrf-2-HO-1 and MAPK, Syk, p38MAPK pathways. There are various melatonin roles in diabetes and DM complications as a promising new breakthrough of DM treatment. It is necessary to explore Melatonin role in other DM complications. Most of this research is on experimental animals, thus clinical trial studies should be carried out in humans to make melatonin a promising therapeutic or prevention for diabetes and its complications in the future

Note: This article has supplementary file(s).

Fulltext View|Download |  Cover letter
Cover letter
Subject
Type Cover letter
  Download (277KB)    Indexing metadata
Keywords: melatonin; diabetes mellitus; complication;signaling pathways
Funding: Directorate of Research and Community Services, Directorate General of Research and Development, Ministry of Research, Technology, and Higher Education, Republic of Indonesia, under the research scheme of Penelitian Kerjasama Antar Perguruan Tinggi, 2019.

Article Metrics:

Article Info
Section: Review Articles
Language : EN
Recent articles
Therapeutic Effect of Red Spinach (Amaranthus tricolor L.) Extract on Pancreatic MDA Levels Rats (Rattus norvegicus) Exposed to MLD-STZ The Effectivity of Parsley (Petroselinum crispum) Extract on The Growth Inhibition of Candida Albicans Diagnostic Value of Vascular Endothelial Growth Factor C (VEGF-C) and CA 15-3 in Breast Cancer Subacute Spinal Subdural Hematoma in One-Year Old Boy Due to Severe Hemophilia A Melatonin, A Promising Therapeutic for Diabetes Mellitus and Its Complications: A Narrative Review More recent articles
  1. World Health Organization. Global status report on noncommunicable diseases 2014. Switzerland.2014
  2. Ministry of Health, Republic of Indonesia. Basic Health Research 2013. Jakarta.2013
  3. Central Java Health Office. Health Profile of Central Java Province 2017.Semarang.2018
  4. Peschke E, T Frese, U Preiss. Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J. Pineal Res.2006;40:135–43
  5. Ramracheya RD, Dany SM, Paul ES, Helen B, David S, Guo CH, Stephanie AA. Function and expression of melatonin receptors on human pancreatic islets. J Sex Med.2008;44:273–9
  6. Peschke E.Melatonin, endocrine pancreas and diabetes.J Sex Med.2008;44:26–40
  7. Peschke E, E Mühlbauer. Best Practice & Research Clinical Endocrinology & Metabolism New evidence for a role of melatonin in glucose regulation. Best Pract. Res. Clin. Endocrinol. Metab.2010;24(5):829–41
  8. Aranda AJ, Gumersindo FV, Maria MAS, Russel JR, Ahmad A. Melatonin improves mitochondrial function in inguinal white adipose tissue of Zucker diabetic fatty rats. J. Pineal Res.2014;57:103–9
  9. Ozkanlar S, A Kara, E Sengul, N Simsek, A Karadeniz, N Kurt. Melatonin Modulates the Immune System Response and Inflammation in Diabetic Rats Experimentally- Induced by Alloxan. Horm Metab Res.2016;48:137–44
  10. Khorsand M, Masoumeh A, Sahab S,Mojtaba B. Melatonin Reduces Cataract Formation and Aldose Reductase Activity in Lenses of Streptozotocin-induced Diabetic Rat. Iran J Med Sci.2016;41(4):305–13
  11. Jiang T, Qing C, Jiyang C, Jiawen F, Xiaozhe Z, Gezhi X. Protective Effects of Melatonin on Retinal Inflammation and Oxidative Stress in Experimental Diabetic Retinopathy. Oxid Med Cell Longev.2016;2016:14–7
  12. Zhang M, Jie L, Shanjie W, Zheng C, Jianqiang H, Tingting W, et.al. Melatonin protects against diabetic cardiomyopathy through Mst1/Sirt3 signaling. J. Pineal Res.2017;63(2)
  13. Zhang JL, Yu H, Feng Z, Jian QH. Neuroprotective effects of melatonin on erectile dysfunction in streptozotocin-induced diabetic rats. Int Urol Nephrol.2018;50(11):1981–8
  14. Qiu XF, Xiao XL,Yun C, Hao CL, Wen Y,Run W, et.al. Mobilisation of endothelial progenitor cells : one of the possible mechanisms involved in the chronic administration of melatonin preventing erectile dysfunction in diabetic rats. Asian J. Androl.2012;14(3): 481–6
  15. Zhou H, Yan Y, Jin W, Qiang M, Yundai C. Melatonin therapy for diabetic cardiomyopathy: A mechanism involving Syk-mitochondrial complex I-SERCA pathway. CelL Signal.2018;47:88–100
  16. Yu Li Ming, Wen C, Xue D, Zhi L, Yong Z, Xiao D, et al. Melatonin protects diabetic heart against ischemia-reperfusion injury, role of membrane receptor-dependent cGMP-PKG activation. Biochim Biophys Acta Mol Basis Dis.2017;1864 (2): 563–78
  17. T. Kaczor. An overview of melatonin and breast cancer. Nat. Med. J.2010; 2(2):1–5
  18. Ritzel RA, Alexandra EB, Robert AR, Johannes DV, Peter CB. Relationship Between β-Cell Mass and Fasting Blood Glucose Concentration in Humans. Diabetes Care.2006; 29(3):717–8
  19. Brand MD, Nicholls DG. Assessing mitochondrial dysfunction in cells. Biochem. J.2011;312:297–312
  20. Zavodnik IB, Lapshina EA, Cheshchevik VT, Dremza IK, Kujawa J, Zabrodskaya SV,et al. Melatonin And Succinate Reduce Rat Liver Mitochondrial Dysfunction In Diabetes. J Physiol Pharmacol.2011; 62(4):421–7
  21. González MA, Maria DCC, Nestor M, Stella TM. Role of melatonin in the oxidative damage prevention at different times of hepatic regeneration. Cell Biochem Funct.2012;30(8):701–8
  22. Yang Y, Weixun D, Zhenxiao J, Wei Y, Juanjuan Y, Song Z, et.al. JAK2 / STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia / reperfusion injury. J. Pineal Res.2013;55: 275–86
  23. Kornatowska KK, Karolina SG, Mariusz K, Hanna P, Jolanta C, Tomasz K, et.al. Melatonin improves oxidative stress parameters measured in the blood of elderly type 2 diabetic patients. J Sex Med.2009;46:333–7
  24. Gil L, Werner S, Birgit M, Johann G, Peter S, Peter V, et.al. Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radic Res.2006;40(5):495–505
  25. Tie L, Xue JL, Xian W, Keith MC, Alex FC. Endothelium-specific GTP cyclohydrolase I overexpression accelerates refractory wound healing by suppressing oxidative stress in diabetes. Am J Physiol Endocrinol Metab.2009;296(13):1423–9
  26. Ozcelik IS. Beneficial Effects of Melatonin on Oxidative Damage Observed During Whole Blood Storage. UHOD.2014;24(2):89–96
  27. Vico AC, Patricia JL, Nuria AS, Ana RR, Juan MG. Melatonin : Buffering the Immune System. Int. J. Mol. Sci.2013;14: 8638–83
  28. Alwadani F, Musad. The Role and Prevalence of Polyol Pathway and Oxidative Stress Markers as Risk Factors for Diabetic Cataract in Adult Type-I Diabetic and Diabetic Cataract Saudi Patients. J Clin Exp Ophthalmol.2016;7(3):1–8
  29. Zhang S, Fei YC, Hong HY, Yong G, Harding JJ. Effects of N-acetylcysteine and glutathione ethyl ester drops on streptozotocin-induced diabetic cataract in rats. Mol Vis.2008;14:862–70
  30. Jiang T, Qing C, Zhenyang Z, Saimei Y, Ling W, Jiyang C, et.al. Melatonin-Mediated Cytoprotection against Hyperglycemic Injury in Muller Cells. PLoS One.2012;7(12):1–8
  31. Wang L, Yan C, Paul S, Jiyang C. Essential Roles of the PI3 Kinase / Akt Pathway in Regulating Nrf2-Dependent Antioxidant Functions in the RPE. IOVS.2008; 49(4):1671–8
  32. Frank A, Megan B, Stephanie B, Lindsay W, Michael K, TobiasE. Myocardial ischemia reperfusion injury - from basic science to clinical bedside. Semin Cardiothorac Vasc Anesth.2012;16(3):123–32
  33. Yu L, Hongliang L, Xiaochao D, Guolong Z, Zhenxiao J, Mengen Z, et.al. Reduced silent information regulator 1 signaling exacerbates myocardial ischemia – reperfusion injury in type 2 diabetic rats and the protective effect of melatonin. J. Pineal Res.2015;59:376–90
  34. Koka S, Hema SA, Lei X, Edward JL, Rakesh CK. Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts : potential role of NO / SIRT1 / PGC-1α signaling. Am J Physiol Hear. Circ Physiol.2014;5:1558–68
  35. Yang Y, Weixun D, Yue L, Zhenxiao J, Juanjuan Y, Shiqiang Y, et.al. Novel role of silent information regulator 1 in myocardial ischemia. Circulation.2013;128(29):2232–40
  36. Jockers R, Philippe D, Margarita LD, Regina PM, Nicolas R, Gianluca T, et.al. Update on Melatonin Receptors. Br J Pharmacol.2016;173(18): 2702–25
  37. Tosini G, Sharon O, Jean LG, Ralf J. Understanding melatonin receptor pharmacology: Latest insights from mouse models, and their relevance to human disease. Bioessays.2014;36(8):778–87
  38. Wang J, Xiaorong H, Hong J. The Nrf-2/ARE–HO-1 axis : An important therapeutic approach for attenuating myocardial ischemia and reperfusion injury-induced cardiac remodeling. Int. J. Cardiol.2015;184:263–4
  39. Das A, Fadi NS, Lei X, Yuan JR, Rakesh CK. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice. Am J Physiol Hear. Circ Physio.2009; 296: 1236–43
  40. Jia G, Michael AH, James RS. An Update of Mechanisms Contributing to This Clinical Entity. Circ Res.2018;122(4): 624–38
  41. Van Nostrand JL, Margot EB, Hannes V, Maria B, Laura DAttardi. The p53 family members have distinct roles during mammalian embryonic development. Cell Death Differ.2017;24(4): 575–9
  42. Kozlov AV, Jack RL, Andras M, Adelhid W. Mitochondria-meditated pathways of organ failure upon inflammation. Redox Biol.2017; 13:170–81
  43. Ding M, Na F, Diashi T, Jaihao F, Zeyang L, Min J, et al. Melatonin prevents Drp1-mediated mitochondrial fission in diabetic hearts through SIRT1-PGC1 α pathway. J. Pineal Res.2018; 65(2):12491
  44. Chiong M, Benjamín CS, Ignacio NS, David MR, Pablo EM, Marina GM, et.al. Mitochondrial metabolism and the control of vascular smooth muscle cell proliferation. Front Cell Div Biol.2014;2:1–9
  45. Ong SB, Andrew RHa, Derek JH. Mitochondrial Dynamics in Cardiovascular. Antioxid Redox Signal.2013;19(4):400-14
  46. Esposito K, Miryam C, Maria IM, Fransesco G, Riccardo A, Marco DS, et.al. Circulating CD34+KDR+ Endothelial Progenitor Cells Correlate with Erectile Function and Endothelial Function in Overweight Men. J Sex Med.2009; 6: 107–14

Last update:

No citation recorded.

Last update:

No citation recorded.